Comparative study of efficacy and safety between bladder body and trigonal intravesical onabotulinumtoxina injection in the treatment of interstitial cystitis refractory to conventional treatment —A prospective, randomized, clinical trial

ConclusionNo significant difference in the improvement of IC symptoms and urodynamic parameters after intravesical BoNT‐A injection in the bladder body or trigone. The rate of adverse events was similar between groups.

Source: Neurourology and Urodynamics - January 13, 2018 Category: Urology & Nephrology Authors: Yuan ‐Hong Jiang, Jia‐Fong Jhang, Cheng‐Ling Lee, Hann‐Chorng Kuo Tags: ORIGINAL CLINICAL ARTICLE Source Type: research